Project Objectives

The project aims at investigating the potential role of different InMed Pharmaceuticals proprietary compounds on the modulation of the various elements of the endocannabinoid system in human keratinocytes, in order to use them as a new therapeutical strategy to cure skin conditions like tumors, psoriasis, atopic dermatitis, acne vulgaris, seborrhea and itchy skin.

Start/End date

2019 - 2021

Principal Investigator

Prof. Mauro Maccarrone - Coordinator

Host Institution

Campus Bio-Medico University of Rome

Other Institutions involved

  • Università degli Studi di Teramo

Source of funding

InMed Pharmaceuticals Inc. (Canada)